Cromwell Holdings’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$67.8K Buy
242
+7
+3% +$1.84K 0.03% 441
2026
Q1
$62.7K Buy
235
+2
+0.9% +$542 0.04% 430
2025
Q4
$58.5K Hold
233
0.03% 437
2025
Q3
$66.9K Buy
233
+1
+0.4% +$268 0.04% 420
2025
Q2
$60.9K Buy
232
+60
+35% +$14.6K 0.04% 424
2025
Q1
$40K Buy
172
+4
+2% +$971 0.03% 495
2024
Q4
$38.5K Hold
168
0.02% 513
2024
Q3
$37.5K Hold
168
0.02% 510
2024
Q2
$34.2K Buy
+168
New +$34.2K 0.02% 515

Other funds holding LH

Cromwell Holdings's LH Position: Q2 2026 in Review

Cromwell Holdings increased its Labcorp (LH) stake by 3% in Q2 2026, buying an estimated $1.84K and bringing the position to 242 shares worth $67.8K. The position accounts for 0.03% of the portfolio, ranked #441.

Cromwell Holdings first reported a position in LH in Q2 2024 and has held it in 9 quarters since. 220 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Cromwell Holdings held 242 shares of Labcorp worth $67.8K as of Q2 2026.
  • Cromwell Holdings bought 7 Labcorp shares in Q2 2026, an estimated $1.84K.
  • Labcorp made up 0.03% of Cromwell Holdings's portfolio in Q2 2026, its #441 holding.
  • Cromwell Holdings first reported a position in Labcorp in Q2 2024 and has held it in 9 quarters since.
  • 220 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Cromwell Holdings's 13F filing for Q2 2026, filed 14 Jul 2026.